Leila Maria de Almeida
Research Interests
Leila Maria de Almeida has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Denner Luiz Cordeiro De Souza
Universidade de Brasília
1 shared publication - Juliana Alves Rodrigues
Centro de Dialise de Cacoal - TRS
1 shared publication - Letícia Gonçalves Grasso
Secretaria Municipal de Saúde de Vilhena
1 shared publication - Ludimila Oliveira Gorini
Centro Universitário Uninassau
1 shared publication - Luiza Putrick da Silva
Centro Universitário UNIFACIMED
1 shared publication - Pâmella Polastry Braga Amaral
Secretaria de Estado e Saúde
1 shared publication
Latest Publications
- Open Access
- 14 February 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (3)
Interfaces entre a cobertura vacinal e a Atenção Primária à Saúde: uma análise retrospectiva da última década em Rondônia
Objective: To analyze the infant and adult vaccination coverage, of all immunizers available by PNI, in the state of Rondônia in the last decade. Methodology: Epidemiological, descriptive and quantitative study conducted through the data available in the Information System of Aggressions and Notification - SINAN, of the Information System of the National Immunization Program (SI-PNI) between the years 2013 and 2022. Results: The vaccination coverage (CV) in the state of Rondônia analyzed throughout this historical series is at 80% and, evidences that, despite the efforts and goals stipulated by PNI, there is still low vaccination coverage in some immunizers, among them, double adult and triple acellular in pregnant women (43.57%), DTP (diphtheria, tetanus and pertussis) reinforcement in children aged 4 and 6 years (44.50%), and dTpa in pregnant women (49.52%). The CV was considered expressive, reaching ≥ 95%, the goal recommended by the MS, especially in the first dose of MMR (103.85%) and DTP (102.87%), other immunizers were between or close to the margin established by the Brazilian Society of Immunization. Final Considerations: several factors are related to low CV in the state of Rondônia, among them, socioeconomic vulnerability, access and precariousness of PHC services. In this sense, it is necessary to expand vaccination coverage, strengthen the PNI, access and integrality of care recommended by SUS and pillars of the Family Health Strategy.
- 14 February 2023
- Published by Research, Society and Development in Research, Society and Development
- Vol. 12 (3)
Open AccessInterfaces entre a cobertura vacinal e a Atenção Primária à Saúde: uma análise retrospectiva da última década em Rondônia
Objective: To analyze the infant and adult vaccination coverage, of all immunizers available by PNI, in the state of Rondônia in the last decade. Methodology: Epidemiological, descriptive and quantitative study conducted through the data available in the Information System of Aggressions and Notification - SINAN, of the Information System of the National Immunization Program (SI-PNI) between the years 2013 and 2022. Results: The vaccination coverage (CV) in the state of Rondônia analyzed throughout this historical series is at 80% and, evidences that, despite the efforts and goals stipulated by PNI, there is still low vaccination coverage in some immunizers, among them, double adult and triple acellular in pregnant women (43.57%), DTP (diphtheria, tetanus and pertussis) reinforcement in children aged 4 and 6 years (44.50%), and dTpa in pregnant women (49.52%). The CV was considered expressive, reaching ≥ 95%, the goal recommended by the MS, especially in the first dose of MMR (103.85%) and DTP (102.87%), other immunizers were between or close to the margin established by the Brazilian Society of Immunization. Final Considerations: several factors are related to low CV in the state of Rondônia, among them, socioeconomic vulnerability, access and precariousness of PHC services. In this sense, it is necessary to expand vaccination coverage, strengthen the PNI, access and integrality of care recommended by SUS and pillars of the Family Health Strategy.